Sienna Biopharmaceuticals, Inc.

SNNAQ · OTC
Analyze with AI
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Assets
Cash & Equivalents$48,526$74,467$9,091$4,962
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,886$2,698$1,323$643
Total Curr. Assets$50,412$77,346$10,523$5,640
Property Plant & Equip (Net)$311$432$291$114
Goodwill$10,989$11,472$9,698$0
Intangibles$45,594$47,597$41,863$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$2$0
Total NC Assets$56,894$59,501$51,854$114
Other Assets$0$0$0$0
Total Assets$107,306$136,847$62,377$5,754
Liabilities
Payables$2,792$2,357$1,691$806
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$21,557$5,884$8,192$203
Total Curr. Liab.$24,349$8,241$9,883$1,009
LT Debt$30,125$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$10,503$10,964$9,325$0
Other NC Liab.$15,748$26,443$21,052$694
Total NC Liab.$56,376$37,407$30,377$694
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$80,725$45,648$40,260$1,703
Equity
Pref Stock$0$0$59,517$20,350
Common Stock$0$2$1$1
Retained Earnings$159,368$85,897-$35,352-$14,190
AOCI$3,199$5,370-$366$0
Other Equity$182,750$171,726-$1,683-$2,110
Total Equity$159,368$85,897$22,117$4,051
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$240,093$131,545$62,377$5,754
Net Debt-$18,401-$74,467-$9,091-$4,962
Sienna Biopharmaceuticals, Inc. (SNNAQ) Financial Statements & Key Stats | AlphaPilot